Attending the European Continuing Medical Education (CME) Forum? Here Are 5 Session Picks
Stakeholders with an interest in European Continuing Medical Education (CME), will meet next week for the 11th Annual European CME Forum.
AI Usage Growing Among Life Sciences Professionals – But Challenges Remain
From entertainment to healthcare, ecommerce to finance – it’s undeniable that the way we do business changes when artificial intelligence… Read more
FDA’s Office of New Drugs Wants in on the Big Data Revolution
The FDA’s Office of New Drugs is being “bombarded” by data and decision-making is suffering as a result. They aren’t alone in this challenge.
Is Knowledge Management Lagging in Fast-Moving Pharma Market?
Keeping up with the pace of change in pharma is a constant battle, but having an efficient knowledge management system in place can give you a head start.
Scientific Search: 5 Key Concepts You Need to Know
How can researchers cope with the deluge of data at their disposal and search more efficiently? Here’s a look at several key scientific search concepts.
Amazon Continues with Bold Pharma Plays, Acquiring Startup Pharmacy PillPack
Amazon recently acquired PillPack – a startup pharmacy that currently serves a small segment of patients who are on a number of different medications.
The Evolving Role of Medical Affairs – And 2 Ways to Keep Up
Medical affairs is a hub of data and information generation, sharing and dissemination. Here are three ways they can help deliver strategic value.
How the FDA Plans to Modernize New Drugs Review Process
The FDA wants to empower the agency’s scientists and medical officers to take on more “thought leadership.” Here’s how they plan to do it.
3 Takeaways for Pharma Orgs from President Trump’s ‘American Patients First’ Speech
Analysts can’t decide whether the “American Patients First” program will serve U.S. consumers well in the long run, but most agreed that the administration is right in attempting to tackle the complex and important issue of drug prices.
Technology a Stumbling Block for Pharma Firms in their Digital Transformation Journey
New research, conducted in Q4 2017 by TayganPoint Consulting Group and PharmaVoice, reveals that more than one in four life sciences companies expect large-scale transformation in the next three years.